Potential role of thiazolidinediones in older diabetic patients.
Umeda
F
F
Third Department of Internal Medicine, School of Medicine, Kyushu University, Fukuoka, Japan.
D000368:Aged; D000375:Aging / Q000378:metabolism; D000818:Animals; D001578:Benzopyrans / Q000627:therapeutic use; D002839:Chromans / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004311:Double-Blind Method; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007333:Insulin Resistance; D007564:Japan; D051379:Mice; D000077205:Pioglitazone; D016032:Randomized Controlled Trials as Topic; D051381:Rats; D013844:Thiazoles / Q000627:therapeutic use; D045162:Thiazolidinediones; D000077288:Troglitazone
D001578:Benzopyrans; D002839:Chromans; D007004:Hypoglycemic Agents; D013844:Thiazoles; D045162:Thiazolidinediones; D000077288:Troglitazone; C039671:ciglitazone; D000077205:Pioglitazone; C066021:englitazone